Contribution of lipids to the pathogenesis of transplant vascular sclerosis.
Wilson
J E
JE
Department of Pathology, St Paul's Hospital-University of British Columbia, Vancouver, Canada.
Wood
S
S
McDonald
P
P
Kenyon
J
J
Dong
C
C
McManus
B M
BM
D000818:Animals; D001053:Apolipoproteins / Q000032:analysis / Q000276:immunology; D001055:Apolipoproteins B / Q000032:analysis / Q000276:immunology; D001057:Apolipoproteins E / Q000032:analysis / Q000276:immunology; D053241:Apoprotein(a); D003324:Coronary Artery Disease / Q000209:etiology* / Q000503:physiopathology; D003331:Coronary Vessels / Q000473:pathology; D004730:Endothelium, Vascular / Q000503:physiopathology; D005487:Foam Cells / Q000473:pathology; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications* / Q000503:physiopathology; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D017270:Lipoprotein(a); D011509:Proteoglycans / Q000502:physiology
D001053:Apolipoproteins; D001055:Apolipoproteins B; D001057:Apolipoproteins E; D008055:Lipids; D017270:Lipoprotein(a); D011509:Proteoglycans; D053241:Apoprotein(a)